175 related articles for article (PubMed ID: 35116415)
1. Sarcopenia and visceral adiposity predict poor overall survival in hepatocellular carcinoma patients after curative hepatic resection.
Jang HY; Choi GH; Hwang SH; Jang ES; Kim JW; Ahn JM; Choi Y; Cho JY; Han HS; Lee J; Chung JW; Baeg JY; Jeong SH
Transl Cancer Res; 2021 Feb; 10(2):854-866. PubMed ID: 35116415
[TBL] [Abstract][Full Text] [Related]
2. Low skeletal muscle mass and high visceral adiposity are associated with recurrence of acute cholecystitis after conservative management: A propensity score-matched cohort study.
Koya Y; Shibata M; Maruno Y; Sakamoto Y; Oe S; Miyagawa K; Honma Y; Harada M
Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):64-70. PubMed ID: 37516589
[TBL] [Abstract][Full Text] [Related]
3. Low psoas muscle index is a poor prognostic factor for lower gastrointestinal perforation: a single-center retrospective cohort study.
Kayano H; Nomura E; Abe R; Ueda Y; Machida T; Fujita C; Uchiyama S; Endo K; Murakami K; Mukai M; Makuuchi H
BMC Surg; 2019 Nov; 19(1):181. PubMed ID: 31779610
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
5. Preoperative prediction of early recurrence of HBV-related hepatocellular carcinoma (≤5 cm) by visceral adipose tissue index.
Wu ZQ; Cheng J; Xiao XX; Zhang HR; Wang J; Peng J; Liu C; Cai P; Li XM
Front Surg; 2022; 9():985168. PubMed ID: 36684155
[TBL] [Abstract][Full Text] [Related]
6. Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
Montano-Loza AJ; Mazurak VC; Ebadi M; Meza-Junco J; Sawyer MB; Baracos VE; Kneteman N
Hepatology; 2018 Mar; 67(3):914-923. PubMed ID: 29023899
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.
Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Seo S; Taura K; Okajima H; Uemoto S
Liver Cancer; 2019 Mar; 8(2):92-109. PubMed ID: 31019900
[TBL] [Abstract][Full Text] [Related]
8. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer.
Minami S; Ihara S; Tanaka T; Komuta K
World J Oncol; 2020 Feb; 11(1):9-22. PubMed ID: 32095185
[TBL] [Abstract][Full Text] [Related]
10. Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality.
Engelmann SU; Pickl C; Haas M; Kaelble S; Hartmann V; Firsching M; Lehmann L; Gužvić M; van Rhijn BWG; Breyer J; Burger M; Mayr R
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980664
[TBL] [Abstract][Full Text] [Related]
11. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
[TBL] [Abstract][Full Text] [Related]
12. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
[TBL] [Abstract][Full Text] [Related]
13. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
Ebadi M; Wang CW; Lai JC; Dasarathy S; Kappus MR; Dunn MA; Carey EJ; Montano-Loza AJ;
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1053-1062. PubMed ID: 30269421
[TBL] [Abstract][Full Text] [Related]
14. Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy.
Yuri Y; Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Hasegawa K; Nakano C; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Takata R; Iijima H; Nishiguchi S
J Cancer; 2017; 8(9):1507-1516. PubMed ID: 28775769
[No Abstract] [Full Text] [Related]
15. Association of magnetic resonance imaging-derived sarcopenia with outcomes of patients with hepatocellular carcinoma after hepatectomy.
Rao C; Chen J; Xu K; Xue C; Wu L; Huang X; Chen S; Rao S; Li F
Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38900325
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia defined by psoas muscle index independently predicts long-term survival after living donor liver transplantation in male recipients.
Tan Y; Duan T; Li B; Zhang B; Zhu Y; Yan K; Song J; Lv T; Yang J; Jiang L; Yang J; Wen T; Yan L
Quant Imaging Med Surg; 2022 Jan; 12(1):215-228. PubMed ID: 34993073
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells.
Zhao M; Duan X; Han X; Wang J; Han G; Mi L; Shi J; Li N; Yin X; Hou J; Yin F
Front Oncol; 2022; 12():854096. PubMed ID: 35463384
[TBL] [Abstract][Full Text] [Related]
18. Adipopenia correlates with higher portal pressure in patients with cirrhosis.
Rodrigues SG; Brabandt B; Stirnimann G; Maurer MH; Berzigotti A
Liver Int; 2019 Sep; 39(9):1672-1681. PubMed ID: 31207018
[TBL] [Abstract][Full Text] [Related]
19. Association of myosteatosis with various body composition abnormalities and longer length of hospitalization in patients with decompensated cirrhosis.
Wang X; Sun M; Li Y; Guo G; Yang W; Mao L; Yu Z; Hui Y; Fan X; Cui B; Jiang K; Sun C
Front Nutr; 2022; 9():921181. PubMed ID: 36185668
[TBL] [Abstract][Full Text] [Related]
20. Increased Visceral Adipose Tissue and Hyperinsulinemia Raise the Risk for Recurrence of Non-B Non-C Hepatocellular Carcinoma after Curative Treatment.
Imai K; Takai K; Miwa T; Maeda T; Hanai T; Shiraki M; Suetsugu A; Shimizu M
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
